SEC22C

Across TCGA pan-cancer cohorts, SEC22C Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated SEC22C data layer compared with 25 for mass-spec protein.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher SEC22C Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SEC22C expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

KIRP, COAD, and UCEC are the cancer types where SEC22C Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Median	All	0.270	0.904	<.001	12	view →
COAD	OS	Median	All	0.001	0.871	<.001	12	view →
UCEC	OS	Median	All	1.000	0.660	.031	8	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

SEC22C–KIRP (OS)

Open the KIRP breakdown →